(Q36685129)

15 August 2017

title

Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T. (English)

1 reference

15 August 2017

Christiane K Kuhl

9

0 references

author name string

Marcus von Falkenhausen

1

1 reference

15 August 2017

Carsten Meyer

2

1 reference

15 August 2017

Götz Lutterbey

3

1 reference

15 August 2017

Nuschin Morakkabati

4

1 reference

15 August 2017

Oliver Walter

5

1 reference

15 August 2017

Jürgen Gieseke

6

1 reference

15 August 2017

Renate Blömer

7

1 reference

15 August 2017

Winfried A Willinek

8

1 reference

15 August 2017

Hans H Schild

10

1 reference

15 August 2017

language of work or name

English

0 references

publication date

15 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

1256-1261

1 reference

Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

15 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00330-006-0484-Y

Superparamagnetic iron oxide particles (SH U 555 A): evaluation of efficacy in three doses for hepatic MR imaging.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00330-006-0484-Y

Hepatic MRI with SPIO: detection and characterization of focal liver lesions

21 January 2018

1 reference

12 December 2020

Clinical experience on 3.0 T systems in Niigata, 1996 to 2002.

1 reference

12 December 2020

Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging--initial experience

1 reference

12 December 2020

MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time

1 reference

12 December 2020

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

1 reference

12 December 2020

Clinical results with Resovist: a phase 2 clinical trial

1 reference

12 December 2020

MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results

1 reference

12 December 2020

Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications

1 reference

12 December 2020

[Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].

1 reference

12 December 2020

Whole-body MRI at high field: technical limits and clinical potential

1 reference

12 December 2020

Magnetic resonance imaging at 3.0 Tesla: challenges and advantages in clinical neurological imaging

1 reference

12 December 2020

Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver

1 reference

12 December 2020

Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study

1 reference

12 December 2020

10.1007/S00330-006-0484-Y

Identifiers

DOI

1 reference

15 August 2017

1 reference